The clinical role of alpha-blockers in the treatment of benign prostatic hyperplasia.

Abstract

Benign prostatic hyperplasia (BPH) is a highly prevalent condition that represents a significant health problem, which is likely to worsen as the population continues to age. alpha-1 adrenoceptor antagonists have been used in the treatment of this condition for well over 20 years and much is now known about their effects on the urinary tract. As these drugs… (More)

Topics

Cite this paper

@article{Oades2000TheCR, title={The clinical role of alpha-blockers in the treatment of benign prostatic hyperplasia.}, author={Grenville M. Oades and John Eaton and R. S. Kirby}, journal={Current urology reports}, year={2000}, volume={1 2}, pages={97-102} }